Abstract
A comparative study of the respiratory burst [monitored as superoxide (O2 −) production] of normal and myeloperoxidase (MPO) -deficient poiymorphonuclear leukocytes (PMNs) was carried out on 11 MPO-deficient subjects that represent the largest sample of this kind ever studied. The rate of O2 − production by isolated PMNs and whole blood from normal and MPO-deficient subjects was comparable during the initial 30–40 min of incubation with serum-treated zymosan (STZ). Afterwards, the amount of O2 − produced became progressively higher in MPO-deficient cells at least until 120 min incubation with STZ. On the contrary the rate of O2 − production by both cell types in response to 4-β-phorbol-12-myristate-13-acetate (PMA) was the same. The PMNs of four MPO-deficient subjects were tested for their ingestion ability by counting the number of ingested particles on toluidine blue-stained sections of epoxy-embedded PMN suspensions. Both cell types ingested STZ particles at a comparable rate at early postphagocytic times, whereas on prolonged incubation MPO-deflcient PMNs ingested more STZ particles than normal PMNs. These results suggest that the ingestion capacity of normal cells may undergo a more rapid deterioration than that of MPO-deficient cells during incubation with STZ. Evidence for a higher deterioration of normal PMNs with respect to MPO-deficient PMNs was obtained also from studies on the effect of storage on O2 − generation. After standing at melting ice temperature for 3 h, normal PMNs produced less O2 − than MPO-deficient PMNs in response to PMA, and the difference in O2 − production by the two cell types in response to STZ was evident at earlier postphagocytic periods than with freshly isolated cells. Taken all together these results suggest that normal PMNs and MPO-deficient PMNs do not intrinsically differ in O2 − generating potential and that the difference in the respiratory burst observed during phagocytosis may be accounted for by a more marked deterioration, in normal PMNs, of one or more functions related to the respiratory burst.
Similar content being viewed by others
References
Clark, R. A. 1983. Extracellular effects of the myeloperoxidase-hydrogen peroxide-halide system.In Advances in Inflammation Research, Vol 5. G. Weissmann, editor. Raven Press, New York. 107–146.
Rosen, H., andS. J. Klebanoff. 1976. Chemiluminescence and superoxide production by myeloperoxidase-deficient leukocytes.J. Clin. Invest. 58:50–60.
Klebanoff, S. J., andS. H. Pincus. 1971. Hydrogen peroxide utilization in myeloperoxidase-deficient leukocytes: A possible microbicidal control mechanism.J. Clin. Invest. 50:2226–2229.
Kitahara, M., H. J. Eyre, Y. Simonian, C. L. Atkin, andS. J. Hassted. 1981, Hereditary myeloperoxidase deficiency.Blood 57:888–893.
Babior, B. M., R. S. Kipnes, andJ. T. Curnutte. 1973. Biological defense mechanism. The production by leukocytes of superoxide, a potential bactericidal agent.J. Clin. Invest. 52:741–744.
Lokwood, W. R. 1964. A reliable and easily sectioned epoxy embedding medium.Anat. Rec. 150:129–134.
Lirm, J. A. 1965. Rapid toluidine blue staining of Epon-embedded and mounted “adjacent” sections.Am. J. Pathol 44:57–65.
Olofsson, T., I. Olsson, P, Venge, andB. Elgefors. 1977. Serum myeloperoxidase and lactoferrin in neutropenia.Scand. J. Haematol. 18:73–84.
Cramer, R., M. R. Soranzo, P. Dri, G. D. Rottini, M, Bramezza, S. Cirielli, andP. Patriarca. 1982. Incidence of myeloperoxidase deficiency in an area of northern Italy: biochemical and functional studies.Br. J. Haematol. 51:81–87.
Dri, P., R. Cramer, M. R. Soranzo, A. Comin, V. Miotti, andP. Patriarca. 1982. New approaches to the detection of myeloperoxidase deficiency.Blood. 60:323–327.
Tauber, A. I., E. J. Goetzl, andB. M. Babior. 1979. Unique characteristics of superoxide production by human eosinophils in eosinophilic states.Inflammation 3:261–272.
Cech, P., A. Papatkanassiou, G. Boreux, P. Roth, andP. A. Miescher. 1979. Hereditary myeloperoxidase deficiency.Blood 53:403–411.
Lehrer, R. I., andR. J. Cline. 1969. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: The role of myeloperoxidase in resistance toCandida infectionsJ. Clin. Invest. 48:1478–1488.
Nauseef, W. M., J. A. Metcalf, andR. K. Root. 1983. Role of myeloperoxidase in the respiratory burst of human neutrophils.Blood 61:483–492.
White, J. G., andR. D. Estensen. 1974. Selective labilization of specific granules in polymorphonuclear leukocytes by phorbol myristate acetate.Am. J. Pathol. 75:45–60.
Wright, D. G., D. A. Bralove, andJ. I. Gallin. 1977. The differential mobilization of human neutrophil granules. Effect of phorbol myristate acetate and ionophore A 23187.Am. J. Pathol. 87:273–284.
Clark, R. A., andS. J. Klebanoff. 1977. Myeloperoxidase-H2O2-halide system: Cytotoxic effect on human blood leukocytes.Blood 50:65–70.
Håkansson, L., andP. Venge. 1982. Kinetic studies of neutrophil phagocytosis. V. Studies on the co-operation between the Fc and C3b receptors. Immunology47:687–694.
Stendahl, O., B. I. Coble, C. Dahlgren, andL. Molin. 1984. Myeloperoxidase modulates the phagocytic activity of polymorphonuclear neutrophil leukocytes. Studies with cells from a myeloperoxidase-deficient patient. J. Clin. Invest.73:366–373.
Harkness, R. A., S. B. Coade, M. Mansell, andR, J. Simmonds. 1982. Nucleotide concentrations in leucocytes and their use in controlling the quality of cell preparations.Adv. Exp. Med. Biol. 141:583–589.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dri, P., Soranzo, M.R., Cramer, R. et al. Role of myeloperoxidase in respiratory burst of human polymorphonuclear leukocytes. Inflammation 9, 21–31 (1985). https://doi.org/10.1007/BF00915408
Issue Date:
DOI: https://doi.org/10.1007/BF00915408